Pills-related severe adverse events: A case report in Taiwan.
Taiwan J Obstet Gynecol
; 55(4): 588-90, 2016 Aug.
Article
en En
| MEDLINE
| ID: mdl-27590388
ABSTRACT
OBJECTIVE:
To review and evaluate the potential adverse effects of these oral contraceptives (OCP) to overweight women. CASE REPORT A 19-year-old college student, with a body mass index (BMI) of 35.2 kg/m(2), who received 2 months of OCP containing cyproterone and ethinyl estradiol for polycystic ovary syndrome (PCOS)-related menstrual problems was complicated with a thromboembolism-related life-threatened disease. After intensive care, including the use of an extracorporeal membrane oxygenation system, thrombolytic treatment, anticoagulant, and inferior vena filter, she recovered well without significant sequelae.CONCLUSION:
This case illustrates the risk of using OCPs, especially for those containing cyproterone and ethinyl estradiol components, as a treatment for menstrual problems in young women with PCOS and a high BMI.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Tromboembolia
/
Anticonceptivos Orales Combinados
/
Ciproterona
/
Etinilestradiol
/
Trastornos de la Menstruación
Tipo de estudio:
Etiology_studies
Límite:
Adult
/
Female
/
Humans
País/Región como asunto:
Asia
Idioma:
En
Revista:
Taiwan J Obstet Gynecol
Asunto de la revista:
GINECOLOGIA
/
OBSTETRICIA
Año:
2016
Tipo del documento:
Article
País de afiliación:
Taiwán